| ★ | Patch Testing, Nickel, & IL-13 Inhibitors: Rethinking Eczematous Dermatitis Diagnosis | | 11 | Estados Unidos | |
| 12 | Beyond Atherosclerosis: Coronary Calcium Scoring in Dyslipidemia, CKM Syndrome | | 2.0K | Estados Unidos | 67 |
| 18 | Furoscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment | | 374 | Estados Unidos | 65 |
| 15 | Aneurysmal Disease Prevention and Treatment Options | Cleveland Clinic @clevelandclinic | 342 | Estados Unidos | 66 |
| 9 | Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD | | 152 | Estados Unidos | 68 |
| 19 | AHA, ACC Release First-Ever Cardiovascular-Kidney-Metabolic Syndrome Guidelines | | 129 | Estados Unidos | 65 |
| 17 | Exa-Cel Approval Expands to Children as Young as 2 With Haydar Frangoul, MD | | 100 | Estados Unidos | 65 |
| 3 | VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes | | 96 | Estados Unidos | 70 |
| 20 | MAESTRO-NASH: Resmetirom May Reduce Cardiovascular Risk in MASH, With or Without Statins | | 86 | Estados Unidos | 65 |
| 2 | SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma | | 78 | Estados Unidos | 70 |
| 8 | How a Nephrologist Diagnoses and Manages Chronic Kidney Disease | | 70 | Estados Unidos | 68 |
| 10 | Prior Authorization, Precision Medicine, and Eczema Remission, With Jason Hawkes, MD | | 69 | Estados Unidos | 67 |
| 6 | Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients | ATS 2026 | | 68 | Estados Unidos | 68 |
| 5 | Omalizumab vs Oral Immunotherapy for Multifood Allergy | | 65 | Estados Unidos | 68 |
| 7 | Closing Gaps in IgA Nephropathy Diagnosis and Treatment, With Brad Rovin, MD | | 60 | Estados Unidos | 68 |
| 11 | Diagnosing Non-IgE Food Hypersensitivity | Brian Lacy, MD, PhD | EAC 2026 | | 31 | Estados Unidos | 67 |
| 14 | Why Quality of Life Can't Take a Back Seat in ISM: Thanai Pongdee, MD, on New PIONEER Data | | 27 | Estados Unidos | 66 |
| 16 | When IBD Symptoms Don't Match Inflammation, With Jordan Axelrad, MD, MPH | | 25 | Estados Unidos | 66 |
| 4 | Key Non-Medication Clinical Pearls for Dermatologists, With Matthew Zirwas, MD | | 21 | Estados Unidos | 69 |
| 1 | Are You Misdiagnosing Atopic Dermatitis? Matthew Zirwas, MD, on Adult-Onset AD | | 19 | Estados Unidos | 72 |
| 13 | How ABCG2 Inhibition Could Change EPP Disease Management | | 17 | Estados Unidos | 67 |